Prolonged Survival of Patients With Metastatic Colorectal Cancer Who Underwent First-line Oxaliplatin Based Chemotherapy With the Introduction of Molecular Targeting Agents and Curative Surgery

被引：0
|
作者：
Shitara, K. [1 ]
Matsuo, K. [2 ]
Kondo, C. [1 ]
Takahari, D. [1 ]
Ura, T. [1 ]
Muro, K. [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi 464, Japan
[2] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)71745-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S421 / S422
页数：2
相关论文
共 50 条
  • [31] Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer
    Baba, H.
    Watanabe, M.
    Okabe, H.
    Miyamoto, Y.
    Sakamoto, Y.
    Baba, Y.
    Iwatsuki, M.
    Chikamoto, A.
    Beppu, T.
    BRITISH JOURNAL OF CANCER, 2012, 107 (12) : 1950 - 1955
  • [32] Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer
    H Baba
    M Watanabe
    H Okabe
    Y Miyamoto
    Y Sakamoto
    Y Baba
    M Iwatsuki
    A Chikamoto
    T Beppu
    British Journal of Cancer, 2012, 107 : 1950 - 1955
  • [33] Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
    Saltz, Leonard B.
    Clarke, Stephen
    Diaz-Rubio, Eduardo
    Scheithauer, Werner
    Figer, Arie
    Wong, Ralph
    Koski, Sheryl
    Lichinitser, Mikhail
    Yang, Tsai-Shen
    Rivera, Fernando
    Couture, Felix
    Sirzen, Florin
    Cassidy, Jim
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 2013 - 2019
  • [34] Angiogenesis gene polymorphisms and clinical outcome of metastatic colorectal cancer treated with first-line bevacizumab and oxaliplatin-based chemotherapy
    Gerger, A.
    Zhang, W.
    Yang, D.
    Bohanes, P. O.
    Ning, Y.
    Winder, T.
    Labonte, M. J.
    Wilson, P. M.
    Benhaim, L.
    El-Khoueiry, R.
    Absenger, G.
    El-Khoueiry, A. B.
    Iqbal, S.
    Lenz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] Surgery with curative intent in patients (pts) treated with first-line chemotherapy (CT) plus bevacizumab (BEV) for metastatic colorectal cancer (mCRC): First BEAT and NO16966
    Cassidy, J.
    Cunningham, D.
    Berry, S. R.
    Rivera, F.
    Clarke, S. J.
    Kretzschmar, A.
    Diaz-Rubio, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] First-Line Mono-Chemotherapy in Frail Elderly Patients with Metastatic Colorectal Cancer
    Varol, Umut
    Dirican, Ahmet
    Yildiz, Ibrahim
    Oktay, Esin
    Degirmenci, Mustafa
    Alacacioglu, Ahmet
    Barutca, Sabri
    Karabulut, Bulent
    Uslu, Ruchan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (07) : 3157 - 3161
  • [37] Elderly patients with metastatic colorectal cancer: overall issues and first-line chemotherapy options
    Benavides, Manuel
    Berciano-Guerrero, Miguel
    COLORECTAL CANCER, 2013, 2 (06) : 559 - 571
  • [38] Capecitabine Maintenance Therapy after First-Line Chemotherapy in Patients with Metastatic Colorectal Cancer
    Yan Li
    Department of GI Oncology
    Chinese Journal of Cancer Research, 2010, 22 (03) : 181 - 185
  • [39] Capecitabine Maintenance Therapy after First-Line Chemotherapy in Patients with Metastatic Colorectal Cancer
    Li, Yan
    Li, Jing
    Lu, Ming
    Wang, Xi-cheng
    Shen, Lin
    CHINESE JOURNAL OF CANCER RESEARCH, 2010, 22 (03) : 181 - 185
  • [40] Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer
    Sorbye, Halfdan
    Berglund, Ake
    Tveit, Kjell Magne
    Ogreid, Dagfinn
    Wanderas, Eva Hoff
    Wentzel-Larsen, Tore
    Dahl, Olav
    Glimelius, Bengt
    ACTA ONCOLOGICA, 2007, 46 (07) : 982 - 988
12345